David Brown
Cardiovascular Disease · Plano, TXNPI 1194717348
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 74.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $14,009 and has fallen 99.3% since, to $100 in 2024.
Across 62 payments — averaging $329.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$15K
- Medtronic$5K
- Sunovion Pharmaceuticals Inc.$127
- Harrow Eye, LLC$100
- Novartis$38
- Tactile Systems Technology Inc$33
- plus $103 from 6 others
Across 274 payments — averaging $7903.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$1.3M
- Boston Scientific$327K
- Medtronic$214K
- Abbott$149K
- Roche TCRC, Inc.$53K
- Sunovion Pharmaceuticals Inc.$51K
- plus $50K from 4 others
Across 17 payments — averaging $29,788 each. An ownership or investment interest held by the physician or an immediate family member.
- Access Vascular Inc$304K
- Heartflow, Inc.$203K
What the payments were for
- Consulting fees$7,50037%
- Speaking & faculty fees$7,00034%
- Travel & lodging$3,24916%
- Food & beverage$2,68213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 39 | $15,301 |
| Medtronic | 10 | $4,730 |
| Sunovion Pharmaceuticals Inc. | 1 | $127 |
| Harrow Eye, LLC | 1 | $100 |
| Novartis | 2 | $38 |
| Tactile Systems Technology Inc | 2 | $33 |
| Boston Scientific | 2 | $29 |
| Abbott | 1 | $20 |
| Johnson & Johnson | 1 | $17 |
| Amgen | 1 | $14 |
| GE HealthCare | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,431 in reported general payments places this provider in the 85th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Plano
- Sahil BakshiPlano$167K
- David RawitscherPlano$122K
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.